Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI

Men with metastatic castration-resistant prostate cancer had a slight but significant improvement in progression-free survival with a TKI plus immunotherapy vs hormonal therapy.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news